{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:12:41Z","timestamp":1793146361918,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11596-022-2568-6","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T18:03:03Z","timestamp":1649872983000},"page":"387-396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Celastrol Induces Apoptosis and Autophagy via the AKT\/mTOR Signaling Pathway in the Pituitary ACTH-secreting Adenoma Cells"],"prefix":"10.1007","volume":"42","author":[{"given":"Zhi","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou-bin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"issue":"2","key":"2568_CR1","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2014.10.FOCUS14700","volume":"38","author":"D Lau","year":"2015","unstructured":"Lau D, Rutledge C, Aghi MK. Cushing\u2019s disease: current medical therapies and molecular insights guiding future therapies. Neurosurg Focus, 2015,38(2):E11","journal-title":"Neurosurg Focus"},{"issue":"9996","key":"2568_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, et al. Cushing\u2019s syndrome. Lancet, 2015,386(9996):913\u2013927","journal-title":"Lancet"},{"issue":"6","key":"2568_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s11102-018-0897-z","volume":"21","author":"LHA Broersen","year":"2018","unstructured":"Broersen LHA, Jha M, Biermasz NR, et al. Effectiveness of medical treatment for Cushing\u2019s syndrome: a systematic review and meta-analysis. Pituitary, 2018, 21(6):631\u2013641","journal-title":"Pituitary"},{"issue":"4","key":"2568_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/er.2013-1048","volume":"36","author":"R Pivonello","year":"2015","unstructured":"Pivonello R, De Leo M, Cozzolino A, et al. The Treatment of Cushing\u2019s Disease. Endocr Rev, 2015,36(4):385\u2013486","journal-title":"Endocr Rev"},{"issue":"3","key":"2568_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1142\/S0192415X14500359","volume":"42","author":"CY Wang","year":"2014","unstructured":"Wang CY, Bai XY, Wang CH. Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development. Am J Chin Med, 2014, 42(3): 543\u2013559","journal-title":"Am J Chin Med"},{"key":"2568_CR6","doi-asserted-by":"publisher","first-page":"110820","DOI":"10.1016\/j.biopha.2020.110820","volume":"132","author":"Y Fan","year":"2020","unstructured":"Fan Y, Ma Z, Zhao L, et al. Anti-tumor activities and mechanisms of Traditional Chinese medicines formulas: A review. Biomed Pharmacother, 2020,132:110820.","journal-title":"Biomed Pharmacother"},{"key":"2568_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jep.2016.10.069","volume":"194","author":"SF Wang","year":"2016","unstructured":"Wang SF, Wu MY, Cai CZ, et al. Autophagy modulators from traditional Chinese medicine: Mechanisms and therapeutic potentials for cancer and neurodegenerative diseases. J Ethnopharmacol, 2016,194:861\u2013876","journal-title":"J Ethnopharmacol"},{"issue":"16","key":"2568_CR8","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1111\/bph.14718","volume":"176","author":"VKW Wong","year":"2019","unstructured":"Wong VKW, Qiu C, Xu SW, et al. Ca(2+) signalling plays a role in celastrol-mediated suppression of synovial fibroblasts of rheumatoid arthritis patients and experimental arthritis in rats. Br J Pharmacol, 2019, 176(16):2922\u20132944","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2568_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","volume":"161","author":"J Liu","year":"2015","unstructured":"Liu J, Lee J, Hernandez MAS, et al. Treatment of obesity with celastrol. Cell, 2015,161(5):999\u20131011","journal-title":"Cell"},{"issue":"4","key":"2568_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41591-019-0358-x","volume":"25","author":"X Feng","year":"2019","unstructured":"Feng X, Guan D, Auen T, et al. IL1R1 is required for celastrol\u2019s leptin-sensitization and antiobesity effects. Nat Med, 2019,25(4):575\u2013582","journal-title":"Nat Med"},{"key":"2568_CR11","doi-asserted-by":"publisher","first-page":"105172","DOI":"10.1016\/j.ejps.2019.105172","volume":"143","author":"X Peng","year":"2020","unstructured":"Peng X, Liang Y, Li J, et al. Preventive effects of \u201covalbumin-conjugated celastrol-loaded nanomicelles\u201d in a mouse model of ovalbumin-induced allergic airway inflammation. Eur J Pharm Sci, 2020,143:105172","journal-title":"Eur J Pharm Sci"},{"issue":"22","key":"2568_CR12","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.7150\/thno.46728","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao Y, Luo W, et al. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells. Theranostics, 2020,10(22):10290\u201310308","journal-title":"Theranostics"},{"key":"2568_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2147\/OTT.S187817","volume":"12","author":"Z Jiang","year":"2019","unstructured":"Jiang Z, Cao Q, Dai G, et al. Celastrol inhibits colorectal cancer through TGF-\u03b21\/Smad signaling. Onco Targets Ther, 2019,12:509\u2013518","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2568_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/10717544.2018.1425778","volume":"25","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Tan Y, Meng T, et al. Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-\u03baB signaling pathway using Celastrol-loaded micelles. Drug Deliv, 2018,25(1):341\u2013352","journal-title":"Drug Deliv"},{"key":"2568_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","volume":"14","author":"Z Su","year":"2015","unstructured":"Su Z, Yang Z, Xu Y, et al. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer, 2015, 14:48","journal-title":"Mol Cancer"},{"issue":"7","key":"2568_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol, 2020,17(7):395\u2013417","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2568_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.biotechadv.2019.02.012","volume":"37","author":"AL Grilo","year":"2019","unstructured":"Grilo AL, Mantalaris A. Apoptosis: A mammalian cell bioprocessing perspective. Biotechnol Adv, 2019, 37(3): 459\u2013475","journal-title":"Biotechnol Adv"},{"issue":"6109","key":"2568_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.1225967","volume":"338","author":"RC Wang","year":"2012","unstructured":"Wang RC, Wei Y, An Z, et al. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science, 2012,338(6109):956\u2013959","journal-title":"Science"},{"issue":"1","key":"2568_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13046-019-1173-4","volume":"38","author":"X Liu","year":"2019","unstructured":"Liu X, Zhao P, Wang X, et al. Celastrol mediates autophagy and apoptosis via the ROS\/JNK and Akt\/mTOR signaling pathways in glioma cells. J Exp Clin Cancer Res, 2019,38(1):184","journal-title":"J Exp Clin Cancer Res"},{"key":"2568_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fphar.2020.00025","volume":"11","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Liu X, Zhao P, et al. Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K\/Akt\/mTOR Signaling Pathway. Front Pharmacol, 2020,11:25","journal-title":"Front Pharmacol"},{"key":"2568_CR21","doi-asserted-by":"publisher","first-page":"8977","DOI":"10.2147\/OTT.S187315","volume":"11","author":"X Li","year":"2018","unstructured":"Li X, Zhu G, Yao X, et al. Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells. Onco Targets Ther, 2018,11:8977\u20138985","journal-title":"Onco Targets Ther"},{"issue":"10","key":"2568_CR22","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s41419-018-1054-3","volume":"9","author":"H Feng","year":"2018","unstructured":"Feng H, Cheng X, Kuang J, et al. Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer. Cell Death Dis, 2018,9(10):1030","journal-title":"Cell Death Dis"},{"issue":"2","key":"2568_CR23","doi-asserted-by":"publisher","first-page":"e12739","DOI":"10.1111\/cpr.12739","volume":"53","author":"J Zhou","year":"2020","unstructured":"Zhou J, Jiang YY, Chen H, et al. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K\/AKT\/mTOR pathway. Cell Prolif, 2020, 53(2): e12739","journal-title":"Cell Prolif"},{"issue":"4","key":"2568_CR24","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1677\/ERC-09-0101","volume":"16","author":"D Dworakowska","year":"2009","unstructured":"Dworakowska D, Wlodek E, Leontiou CA, et al. Activation of RAF\/MEK\/ERK and PI3K\/AKT\/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer, 2009, 16(4): 1329\u20131338","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"2568_CR25","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/cr.2016.114","volume":"26","author":"ZJ Song","year":"2016","unstructured":"Song ZJ, Reitman ZJ, Ma ZY, et al. The genome-wide mutational landscape of pituitary adenomas. Cell Res, 2016,26(11):1255\u20131259","journal-title":"Cell Res"},{"key":"2568_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2018.07.007","volume":"478","author":"K Jin","year":"2018","unstructured":"Jin K, Ruan L, Pu J, et al. Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells. Mol Cell Endocrinol, 2018,478:53\u201361","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2568_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12020-016-0984-8","volume":"56","author":"R Pivonello","year":"2017","unstructured":"Pivonello R, De Martino MC, De Leo, et al. Cushing\u2019s disease: the burden of illness. Endocrine, 2017,56(1):10\u201318","journal-title":"Endocrine"},{"issue":"2","key":"2568_CR28","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3171\/2016.1.JNS152119","volume":"126","author":"RR Lonser","year":"2017","unstructured":"Lonser RR, Nieman L, Oldfield EH. Cushing\u2019s disease: pathobiology, diagnosis, and management. J Neurosurg, 2017,126(2):404\u2013417","journal-title":"J Neurosurg"},{"key":"2568_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phymed.2018.09.181","volume":"54","author":"FZ Lin","year":"2019","unstructured":"Lin FZ, Wang SC, Hsi YT, et al. Celastrol induces vincristine multidrug resistance oral cancer cell apoptosis by targeting JNK1\/2 signaling pathway. Phytomedicine, 2019,54:1\u20138","journal-title":"Phytomedicine"},{"issue":"1","key":"2568_CR30","doi-asserted-by":"publisher","first-page":"e1604","DOI":"10.1038\/cddis.2014.543","volume":"6","author":"HY Li","year":"2015","unstructured":"Li HY, Zhang J, Sun LL, et al. Celastrol induces apoptosis and autophagy via the ROS\/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study. Cell Death Dis, 2015,6(1):e1604","journal-title":"Cell Death Dis"},{"issue":"2","key":"2568_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol, 2018,15(2):81\u201394","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2568_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2013.04.026","volume":"336","author":"R Emmanuel","year":"2013","unstructured":"Emmanuel R, Weinstein S, Landesman-Milo D, et al. eIF3c: a potential therapeutic target for cancer. Cancer Lett, 2013,336(1):158\u2013166","journal-title":"Cancer Lett"},{"key":"2568_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1476-4598-9-79","volume":"9","author":"B Peng","year":"2010","unstructured":"Peng B, Xu L, Cao F, et al. HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0\/G1 in thiol-containing agents reversible way. Mol Cancer, 2010,9:79","journal-title":"Mol Cancer"},{"issue":"7","key":"2568_CR34","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/cdd.2015.50","volume":"22","author":"AR Delbridge","year":"2015","unstructured":"Delbridge AR, Strasser A. The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ, 2015,22(7):1071\u20131080","journal-title":"Cell Death Differ"},{"issue":"1","key":"2568_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1517\/14728222.2014.961425","volume":"19","author":"B Kim","year":"2015","unstructured":"Kim B, Srivastava SK, Kim SH. Caspase-9 as a therapeutic target for treating cancer. Expert Opin Ther Targets, 2015,19(1):113\u2013127","journal-title":"Expert Opin Ther Targets"},{"key":"2568_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mito.2019.07.003","volume":"49","author":"Y Wu","year":"2019","unstructured":"Wu Y, Chen M, Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion, 2019,49:35\u201345","journal-title":"Mitochondrion"},{"issue":"16","key":"2568_CR37","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1002\/cncr.31335","volume":"124","author":"AV Onorati","year":"2018","unstructured":"Onorati AV, Dyczynski M, Ojha R, et al. Targeting autophagy in cancer. Cancer, 2018,124(16):3307\u20133318","journal-title":"Cancer"},{"key":"2568_CR38","doi-asserted-by":"publisher","first-page":"100752","DOI":"10.1016\/j.drup.2021.100752","volume":"56","author":"T Jiang","year":"2021","unstructured":"Jiang T, Chen X, Ren X, et al. Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance. Drug Resist Updat, 2021,56:100752","journal-title":"Drug Resist Updat"},{"issue":"11\u201312","key":"2568_CR39","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1101\/gad.325514.119","volume":"33","author":"L Poillet-Perez","year":"2019","unstructured":"Poillet-Perez L, White E. Role of tumor and host autophagy in cancer metabolism. Genes Dev, 2019, 33(11\u201312):610\u2013619","journal-title":"Genes Dev"},{"issue":"10","key":"2568_CR40","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.7150\/ijbs.58715","volume":"17","author":"YN Shi","year":"2021","unstructured":"Shi YN, Liu LP, Deng CF, et al. Celastrol ameliorates vascular neointimal hyperplasia through Wnt5a-involved autophagy. Int J Biol Sci, 2021,17(10):2561\u20132575","journal-title":"Int J Biol Sci"},{"key":"2568_CR41","doi-asserted-by":"publisher","first-page":"5532269","DOI":"10.1155\/2021\/5532269","volume":"2021","author":"L Wang","year":"2021","unstructured":"Wang L, Tang L, Yao C, et al. The Synergistic Effects of Celastrol in combination with Tamoxifen on Apoptosis and Autophagy in MCF-7 Cells. J Immunol Res, 2021, 2021:5532269","journal-title":"J Immunol Res"},{"issue":"8","key":"2568_CR42","doi-asserted-by":"publisher","first-page":"12562","DOI":"10.1002\/jcp.28125","volume":"234","author":"B Shi","year":"2019","unstructured":"Shi B, Ma M, Zheng Y, et al. mTOR and Beclin1: Two key autophagy-related molecules and their roles in myocardial ischemia\/reperfusion injury. J Cell Physiol, 2019,234(8):12562\u201312568","journal-title":"J Cell Physiol"},{"issue":"1","key":"2568_CR43","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jcp.26855","volume":"234","author":"MA Rodr\u00edguez-Hern\u00e1ndez","year":"2018","unstructured":"Rodr\u00edguez-Hern\u00e1ndez MA, Gonz\u00e1lez R, de la Rosa \u00c1 J, et al. Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells. J Cell Physiol, 2018,234(1):692\u2013708","journal-title":"J Cell Physiol"},{"issue":"11","key":"2568_CR44","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1158\/0008-5472.CAN-17-3024","volume":"78","author":"M Rahmani","year":"2018","unstructured":"Rahmani M, Nkwocha J, Hawkins E, et al. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells. Cancer Res, 2018, 78(11): 3075\u20133086","journal-title":"Cancer Res"},{"issue":"2","key":"2568_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/jnc.12474","volume":"128","author":"S Chen","year":"2014","unstructured":"Chen S, Gu C, Xu C, et al. Celastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt\/mTOR network. J Neurochem, 2014,128(2):256\u2013266","journal-title":"J Neurochem"},{"key":"2568_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ebiom.2019.10.062","volume":"50","author":"DS Metselaar","year":"2019","unstructured":"Metselaar DS, Meel MH, Benedict B, et al. Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin. EBioMedicine, 2019,50:81\u201392","journal-title":"EBioMedicine"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2568-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-022-2568-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2568-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T22:18:56Z","timestamp":1671229136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-022-2568-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2568"],"URL":"https:\/\/doi.org\/10.1007\/s11596-022-2568-6","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}},{"value":"Author Ting LEI is a member of the Editorial Board for Current Medical Science. The paper was handled by the other editor and has undergone rigorous peer review process. Author Ting LEI was not involved in the journal\u2019s review of, or decision related to, this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}